Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

GNFT

Genfit (GNFT)

Genfit
から:
次の項目別のソート:
 Showing the most relevant articles for your search:EU:GNFT
日付受信時刻ニュースソース見出しコード企業名
2024/11/1406 : 10GlobeNewswire Inc.GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024EU:GNFTGenfit
2024/11/0806 : 10GlobeNewswire Inc.GENFIT Reports Third Quarter 2024 Financial InformationEU:GNFTGenfit
2024/09/2314 : 30GlobeNewswire Inc.GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated ApprovalEU:GNFTGenfit
2024/09/2005 : 10GlobeNewswire Inc.GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate UpdateEU:GNFTGenfit
2024/07/2620 : 45GlobeNewswire Inc.GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary CholangitisEU:GNFTGenfit
2024/06/1805 : 10GlobeNewswire Inc.GENFIT : Les nouvelles recommandations de pratique clinique de l'EASL-EASD-EASO pour la MASLD incluent NIS2+® comme outil-clé pour la détection de la MASH à risque  EU:GNFTGenfit
2024/06/1805 : 10GlobeNewswire Inc.GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASHEU:GNFTGenfit
2024/06/1805 : 10GlobeNewswire Inc.GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASHEU:GNFTGenfit
2024/06/1106 : 22GlobeNewswire Inc.GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaineEU:GNFTGenfit
2024/06/1106 : 22GlobeNewswire Inc.GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary CholangitisEU:GNFTGenfit
2024/06/1106 : 22GlobeNewswire Inc.GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary CholangitisEU:GNFTGenfit
2024/05/3005 : 10GlobeNewswire Inc.GENFIT présentera ses dernières avancées dans l'ACLF à l'EASL Congress™ 2024  EU:GNFTGenfit
2024/05/3005 : 10GlobeNewswire Inc.GENFIT to Present Latest ACLF Research at EASL Congress™ 2024EU:GNFTGenfit
2024/05/3005 : 10GlobeNewswire Inc.GENFIT to Present Latest ACLF Research at EASL Congress™ 2024EU:GNFTGenfit
2024/05/2301 : 05GlobeNewswire Inc.GENFIT: May 22, 2024 Combined Shareholders Meeting ResultsEU:GNFTGenfit
2024/05/2301 : 05GlobeNewswire Inc.GENFIT : Résultats de l’Assemblée Générale Mixte du 22 mai 2024EU:GNFTGenfit
2024/05/2301 : 05GlobeNewswire Inc.GENFIT: May 22, 2024 Combined Shareholders Meeting ResultsEU:GNFTGenfit
2024/05/1505 : 10GlobeNewswire Inc.GENFIT : Information financière du premier trimestre 2024EU:GNFTGenfit
2024/05/1505 : 10GlobeNewswire Inc.GENFIT Reports First Quarter 2024 Financial InformationEU:GNFTGenfit
2024/05/1505 : 10GlobeNewswire Inc.GENFIT Reports First Quarter 2024 Financial InformationEU:GNFTGenfit
2024/04/2605 : 10GlobeNewswire Inc.GENFIT : Publication du rapport de performance extra-financière 2024 (exercice 2023)EU:GNFTGenfit
2024/04/2605 : 10GlobeNewswire Inc.GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)EU:GNFTGenfit
2024/04/2605 : 10GlobeNewswire Inc.GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)EU:GNFTGenfit
2024/04/1605 : 10GlobeNewswire Inc.GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory DocumentsEU:GNFTGenfit
2024/04/1605 : 10GlobeNewswire Inc.GENFIT : Assemblée Générale Mixte du 22 mai 2024 — modalités de mise à disposition des documents préparatoires EU:GNFTGenfit
2024/04/1605 : 10GlobeNewswire Inc.GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory DocumentsEU:GNFTGenfit
2024/04/0603 : 00GlobeNewswire Inc.GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-FEU:GNFTGenfit
2024/04/0603 : 00GlobeNewswire Inc.GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-FEU:GNFTGenfit
2024/04/0603 : 00GlobeNewswire Inc.GENFIT : Mise à disposition du Document d’Enregistrement Universel 2023 et du Rapport Annuel Form 20-F 2023EU:GNFTGenfit
2024/04/0505 : 10GlobeNewswire Inc.GENFIT : Résultats financiers annuels 2023 et point sur les activités de la SociétéEU:GNFTGenfit
 Showing the most relevant articles for your search:EU:GNFT

最近閲覧した銘柄